Preview

Drug development & registration

Advanced search

About the Perm Cluster Development Center pharmaceutical industry "PARMA"

Abstract

On November 9, 2022, between the Government of the Perm Territory, the Perm State Pharmaceutical Academy of the Ministry of Health of Russia (hereinafter referred to as PGFA) and the Autonomous Non-Profit Organization "Perm Scientific and Educational Center of the World Level "Rational Subsoil Use" (hereinafter referred to as the Perm REC) signed an Agreement on the establishment of the Perm Center cluster development of the pharmaceutical industry "PARMA" (hereinafter - CKR PARMA). The purpose of the Agreement is to create a material and technical, scientific, technological and intellectual environment that ensures the provision of a wide range of educational and scientific services within the framework of the full life cycle of pharmaceutical products (from development to sales).

About the Author

article Editorial

Russian Federation


Supplementary files

1. Графический абстракт
Subject
Type Исследовательские инструменты
View (1MB)    
Indexing metadata ▾

Review

For citations:


About the Perm Cluster Development Center pharmaceutical industry "PARMA". Drug development & registration. 2022;11(4):10-12. (In Russ.)

Views: 3573


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)